Monitoring artificial pancreas trials through agent-based technologies: A case report

Giordano Lanzola, Stefania Scarpellini, Federico Di Palma, Chiara Toffanin, Simone Del Favero, Lalo Magni, Riccardo Bellazzi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The increase in the availability and reliability of network connections lets envision systems supporting a continuous remote monitoring of clinical parameters useful either for overseeing chronic diseases or for following clinical trials involving outpatients. We report here the results achieved by a telemedicine infrastructure that has been linked to an artificial pancreas platform and used during a trial of the AP@home project, funded by the European Union. The telemedicine infrastructure is based on a multiagent paradigm and is able to deliver to the clinic any information concerning the patient status and the operation of the artificial pancreas. A web application has also been developed, so that the clinic staff and the researchers involved in the design of the blood glucose control algorithms are able to follow the ongoing experiments. Albeit the duration of the experiments in the trial discussed in the article was limited to only 2 days, the system proved to be successful for monitoring patients, in particular overnight when the patients are sleeping. Based on that outcome we can conclude that the infrastructure is suitable for the purpose of accomplishing an intelligent monitoring of an artificial pancreas either during longer trials or whenever that system will be used as a routine treatment.

Original languageEnglish
Pages (from-to)216-224
Number of pages9
JournalJournal of diabetes science and technology
Volume8
Issue number2
DOIs
Publication statusPublished - Mar 1 2014

Fingerprint

Artificial Pancreas
Telemedicine
Technology
Patient monitoring
Monitoring
Glucose
Blood Glucose
Blood
Experiments
Availability
Physiologic Monitoring
European Union
Chronic Disease
Outpatients
Research Personnel
Clinical Trials
Therapeutics

Keywords

  • Artificial pancreas
  • Clinical trial
  • Diabetes mellitus type 1
  • Remote monitoring
  • Telemedicine

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Bioengineering
  • Medicine(all)
  • Biomedical Engineering

Cite this

Monitoring artificial pancreas trials through agent-based technologies : A case report. / Lanzola, Giordano; Scarpellini, Stefania; Di Palma, Federico; Toffanin, Chiara; Del Favero, Simone; Magni, Lalo; Bellazzi, Riccardo.

In: Journal of diabetes science and technology, Vol. 8, No. 2, 01.03.2014, p. 216-224.

Research output: Contribution to journalArticle

Lanzola, Giordano ; Scarpellini, Stefania ; Di Palma, Federico ; Toffanin, Chiara ; Del Favero, Simone ; Magni, Lalo ; Bellazzi, Riccardo. / Monitoring artificial pancreas trials through agent-based technologies : A case report. In: Journal of diabetes science and technology. 2014 ; Vol. 8, No. 2. pp. 216-224.
@article{cb3a6f1439b34d899c86b8fffc779150,
title = "Monitoring artificial pancreas trials through agent-based technologies: A case report",
abstract = "The increase in the availability and reliability of network connections lets envision systems supporting a continuous remote monitoring of clinical parameters useful either for overseeing chronic diseases or for following clinical trials involving outpatients. We report here the results achieved by a telemedicine infrastructure that has been linked to an artificial pancreas platform and used during a trial of the AP@home project, funded by the European Union. The telemedicine infrastructure is based on a multiagent paradigm and is able to deliver to the clinic any information concerning the patient status and the operation of the artificial pancreas. A web application has also been developed, so that the clinic staff and the researchers involved in the design of the blood glucose control algorithms are able to follow the ongoing experiments. Albeit the duration of the experiments in the trial discussed in the article was limited to only 2 days, the system proved to be successful for monitoring patients, in particular overnight when the patients are sleeping. Based on that outcome we can conclude that the infrastructure is suitable for the purpose of accomplishing an intelligent monitoring of an artificial pancreas either during longer trials or whenever that system will be used as a routine treatment.",
keywords = "Artificial pancreas, Clinical trial, Diabetes mellitus type 1, Remote monitoring, Telemedicine",
author = "Giordano Lanzola and Stefania Scarpellini and {Di Palma}, Federico and Chiara Toffanin and {Del Favero}, Simone and Lalo Magni and Riccardo Bellazzi",
year = "2014",
month = "3",
day = "1",
doi = "10.1177/1932296814522120",
language = "English",
volume = "8",
pages = "216--224",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "2",

}

TY - JOUR

T1 - Monitoring artificial pancreas trials through agent-based technologies

T2 - A case report

AU - Lanzola, Giordano

AU - Scarpellini, Stefania

AU - Di Palma, Federico

AU - Toffanin, Chiara

AU - Del Favero, Simone

AU - Magni, Lalo

AU - Bellazzi, Riccardo

PY - 2014/3/1

Y1 - 2014/3/1

N2 - The increase in the availability and reliability of network connections lets envision systems supporting a continuous remote monitoring of clinical parameters useful either for overseeing chronic diseases or for following clinical trials involving outpatients. We report here the results achieved by a telemedicine infrastructure that has been linked to an artificial pancreas platform and used during a trial of the AP@home project, funded by the European Union. The telemedicine infrastructure is based on a multiagent paradigm and is able to deliver to the clinic any information concerning the patient status and the operation of the artificial pancreas. A web application has also been developed, so that the clinic staff and the researchers involved in the design of the blood glucose control algorithms are able to follow the ongoing experiments. Albeit the duration of the experiments in the trial discussed in the article was limited to only 2 days, the system proved to be successful for monitoring patients, in particular overnight when the patients are sleeping. Based on that outcome we can conclude that the infrastructure is suitable for the purpose of accomplishing an intelligent monitoring of an artificial pancreas either during longer trials or whenever that system will be used as a routine treatment.

AB - The increase in the availability and reliability of network connections lets envision systems supporting a continuous remote monitoring of clinical parameters useful either for overseeing chronic diseases or for following clinical trials involving outpatients. We report here the results achieved by a telemedicine infrastructure that has been linked to an artificial pancreas platform and used during a trial of the AP@home project, funded by the European Union. The telemedicine infrastructure is based on a multiagent paradigm and is able to deliver to the clinic any information concerning the patient status and the operation of the artificial pancreas. A web application has also been developed, so that the clinic staff and the researchers involved in the design of the blood glucose control algorithms are able to follow the ongoing experiments. Albeit the duration of the experiments in the trial discussed in the article was limited to only 2 days, the system proved to be successful for monitoring patients, in particular overnight when the patients are sleeping. Based on that outcome we can conclude that the infrastructure is suitable for the purpose of accomplishing an intelligent monitoring of an artificial pancreas either during longer trials or whenever that system will be used as a routine treatment.

KW - Artificial pancreas

KW - Clinical trial

KW - Diabetes mellitus type 1

KW - Remote monitoring

KW - Telemedicine

UR - http://www.scopus.com/inward/record.url?scp=84992236292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992236292&partnerID=8YFLogxK

U2 - 10.1177/1932296814522120

DO - 10.1177/1932296814522120

M3 - Article

AN - SCOPUS:84992236292

VL - 8

SP - 216

EP - 224

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 2

ER -